Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Voyageur Pharmaceuticals Ltd. VYYRF

Full chart Compare
Set alert

Price alert · VYYRF

All alert types
0.02 USD 0.00 (+0.00%)

At closeNov 2, 2026, 4:00 PM EST

0.087 Day range 0.087
0.0033 52-week range 1.03
YTD
-84.63%
1 year
-81.65%

Financial health

Altman Z-Score

-1.47 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E -6.6×
FY 2016: -1.5×FY 2017: -4.1×FY 2018: -6.5×FY 2019: -5.8×FY 2020: -2.8×FY 2021: -4.6×FY 2022: -5.8×FY 2023: -4.1×FY 2024: -0.2×FY 2025: -6.6×
FY 2016 5y median -4.6× FY 2025
P/S 1983×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 1983×
FY 2016 5y median 0.0× FY 2025
P/B 18.5×
FY 2016: 0.1×FY 2017: -30.5×FY 2018: 7.1×FY 2019: 4.2×FY 2020: 10.5×FY 2021: 4.9×FY 2022: 6.9×FY 2023: 4.0×FY 2024: 0.0×FY 2025: 18.5×
FY 2016 5y median 4.9× FY 2025
P/FCF -8.0×
FY 2016: -0.4×FY 2017: -2.4×FY 2018: -4.5×FY 2019: -5.0×FY 2020: -7.4×FY 2021: -4.5×FY 2022: -5.1×FY 2023: -5.8×FY 2024: -0.0×FY 2025: -8.0×
FY 2016 5y median -5.1× FY 2025
EV/EBITDA -6.5×
FY 2016: 1188×FY 2017: -28.7×FY 2018: 0.0×FY 2019: -5.9×FY 2020: -3.1×FY 2021: -4.2×FY 2022: -5.8×FY 2023: -4.8×FY 2024: -2235×FY 2025: -6.5×
FY 2016 5y median -5.8× FY 2025
EV/Sales 1963×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 1963×
FY 2016 5y median 0.0× FY 2025
FCF Yield -12.5%
FY 2016: -250.6%FY 2017: -42.5%FY 2018: -22.3%FY 2019: -20.1%FY 2020: -13.5%FY 2021: -22.2%FY 2022: -19.8%FY 2023: -17.1%FY 2024: -78450.9%FY 2025: -12.5%
FY 2016 5y median -19.8% FY 2025

Profitability

Gross Margin -10466.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -10466.9%
FY 2016 5y median 0.0% FY 2025
Operating Margin -30232.7%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -30232.7%
FY 2016 5y median 0.0% FY 2025
Net Margin -30232.7%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -30232.7%
FY 2016 5y median 0.0% FY 2025
ROE -282.1%
FY 2016: -7.8%FY 2017: 751.7%FY 2018: -107.8%FY 2019: -73.2%FY 2020: -372.0%FY 2021: -107.6%FY 2022: -119.8%FY 2023: -97.5%FY 2024: -0.4%FY 2025: -282.1%
FY 2016 5y median -107.6% FY 2025
ROIC -273.3%
FY 2016: -5.4%FY 2017: -167.0%FY 2018: -32.5%FY 2019: -61.2%FY 2020: -144.2%FY 2021: -100.5%FY 2022: -116.3%FY 2023: -82.0%FY 2024: -0.3%FY 2025: -273.3%
FY 2016 5y median -100.5% FY 2025
ROA -113.8%
FY 2016: -7.4%FY 2017: -77.1%FY 2018: -43.9%FY 2019: -34.4%FY 2020: -89.4%FY 2021: -79.9%FY 2022: -83.7%FY 2023: -64.7%FY 2024: -0.1%FY 2025: -113.8%
FY 2016 5y median -79.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -233109.6%
FY 2016: -3430.6%FY 2017: -1076.1%FY 2018: -86.8%FY 2019: 51.7%FY 2020: -53.0%FY 2021: -132.3%FY 2022: 11.3%FY 2023: 30.2%FY 2024: 99.9%FY 2025: -233109.6%
FY 2016 FY 2025
EPS (diluted) -71.0%
FY 2016: -3360.0%FY 2017: 64.5%FY 2018: 36.4%FY 2019: 17.9%FY 2020: -68.8%FY 2021: -34.0%FY 2022: 24.9%FY 2023: 34.4%FY 2024: -15.9%FY 2025: -71.0%
FY 2016 FY 2025
Free Cash Flow -855.9%
FY 2016: -76.0%FY 2017: -482.3%FY 2018: 29.9%FY 2019: 21.2%FY 2020: 32.1%FY 2021: -380.6%FY 2022: 4.1%FY 2023: 50.5%FY 2024: 69.5%FY 2025: -855.9%
FY 2016 FY 2025

Financial Health

Current Ratio 0.3×
FY 2016: 18.3×FY 2017: 0.2×FY 2018: 0.4×FY 2019: 0.5×FY 2020: 0.0×FY 2021: 1.4×FY 2022: 0.3×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.3×
FY 2016 5y median 0.3× FY 2025
Quick Ratio 0.3×
FY 2016: 18.7×FY 2017: 0.3×FY 2018: 0.4×FY 2019: 0.5×FY 2020: 0.0×FY 2021: 1.4×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.3×
FY 2016 5y median 0.2× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: -0.6×FY 2018: 0.3×FY 2019: 0.2×FY 2020: 0.9×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2016: 1340×FY 2017: -0.3×FY 2018: 0.0×FY 2019: -0.1×FY 2020: -0.2×FY 2021: 0.4×FY 2022: 0.0×FY 2023: -0.0×FY 2024: -2242×FY 2025: 0.1×
FY 2016 5y median 0.0× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -45.5×FY 2021: -602×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-11-30